Twist form of teleocidin derivatives is active in in vivo tumor promotion by (-)-Benzolactam-V8-310

Biological and Pharmaceutical Bulletin

Volumn 21, Issue 5, 1998, Pages 465-468

  Okabe, Sachiko ^a   Sueoka, Naoko ^a   Komori, Atsumasa ^a   Suganuma, Masami ^a   Endo, Yasuyuki ^b   Shudo, Koichi ^b   Fujiki, Hirota ^a  

^a SAITAMA CANCER CENTER   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Benzolactam; Teleocidin; Tumor necrosis factor ; Tumor promoter; Twist form

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; BENZOLACTAM V8 310; PHORBOL 13 ACETATE 12 MYRISTATE; TELEOCIDIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; DOSE RESPONSE; DRUG CONFORMATION; FEMALE; HUMAN; HUMAN CELL; INHIBITION KINETICS; MOUSE; NONHUMAN; RECEPTOR BINDING; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; TUMOR PROMOTION;

EID: 0031808416     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.21.465     Document Type: Article

References (12)

1. Fujiki H., Sugimura T., Adv. Cancer Res., 49, 223-264 (1987).
2. Fujiki H., Suganuma M., Ninomiya M., Yoshizawa S., Yamashita K., Takayama S., Hitotsuyanagi Y., Sakai S., Shudo K., Sugimura T., Cancer Res., 48, 4211-4214 (1988).
3. Itai A., Matsuo A., Mizutani M.Y., Tomioka N., Shitaka M.T., Endo Y., Shudo K., Chem. Pharm. Bull., 45, 573-575 (1997).
4. Endo Y., Shudo K., Itai A., Hasegawa M., Sakai S., Tetrahedron, 42, 5905-5924 (1986).
5. Ohno M., Endo Y., Hirano M., Itai A., Shudo K., Tetrahedron Lett., 34, 8119-8122 (1993).
6. Endo Y., Ohno M., Hirano M., Itai A., Shudo K., J. Am. Chem. Soc., 118, 1841-1855 (1996).
7. Endo Y., Yamaguchi M., Hirano M., Shudo K., Chem. Pharm. Bull., 44, 1138-1140 (1996).
8. Suganuma M., Fujiki H., Tahira T., Cheuk C., Moore R. E., Sugimura T., Carcinogenesis, 5, 315-318 (1984).
9. Komori A., Yatsunami J., Suganuma M., Okabe S., Abe S., Sakai A., Sasaki K., Fujiki H., Cancer Res., 53. 1982-1985 (1993).
10. Fujiki H., Sueoka E, Komori A., Suganuma M., Environ. Carcino. & Ecotox. Revs., C15, 1-40 (1997).
11. Hashimoto Y., Shudo K., Jpn. J. Cancer Res., 82, 665-675 (1991).
12. Azuma A., Ando Y., Iwasaki S., Hashimoto Y., Yamaguchí M., Takehana S., Fukasawa H., Endo Y., Shudo K., Biol. Pharm. Bull., 20, 6-9 (1997).